AstraZeneca said to have explored Bristol Myers merger

Fortune•Sun, Aug 2, 2026, 09:27 PM•2 min read

Bristol Myers Squibb, which has a $133 billion market capitalization, could provide AstraZeneca with a bigger foothold in the US market.

Source: [Fortune](https://fortune.com/2026/08/02/astrazeneca-bristol-myers-squibb-merger-patents-us-market/)

📰 Read Full Story

This is an aggregated headline summary. For the complete report, visit the original publisher.

More Headlines

BusinessFortune• 35m ago

Experts say shortages are forcing companies to explore Chinese chip supplies, yet adoption is still likely to be selective and politically contested.

BusinessFortune• 1h ago

“Demand is concentrating around experienced workers and roles directly connected to AI, rather than flowing evenly through the profession.

FinanceYahoo Finance• 1h ago

Developing story — details emerging. Check the source link for the latest updates.

FinanceInvesting.com• 1h ago

Developing story — details emerging. Check the source link for the latest updates.

BusinessBusiness Insider• 1h ago

I landed in Cape Verde and soon got myself into a classic situationship. Now I'm working to be true to myself and my needs.

BusinessInc.• 1h ago

A North Dakota operator with multiple Subway restaurants has filed for bankruptcy, raising questions about what happens to its locations next.